Dr Agarwals Eye Hospital and Menicon have begun clinical studies in India using Menicon Bloom Night
Dr Agarwals Eye Hospital announced its partnership with Menicon Co, a global pioneer in contact lens innovation operating in more than 80 countries worldwide. The partnership aims to drive research and development in myopia control treatment, especially in India.
Dr Agarwals Eye Hospital in collaboration with Menicon, backed by the Japanese Government, has initiated a study to explore effective strategies for controlling and mitigating these vision-related issues.
This landmark clinical study was launched by the Research and Development Unit of the Clinical Board of Dr Agarwals Eye Hospital in February 2025 aiming to analyse the rising cases of myopia in Indian children. This collaboration strengthened by an MoU not only sets a foundation for joint R&D in myopia but also outlines training ophthalmologists and optometrists, patient awareness drives and expansion plans for contact lens business in India and the neighbouring regions.
Dr Agarwals Eye Hospital and Menicon have begun clinical studies in India using Menicon Bloom Night, an orthokeratology lens which is worn overnight to improve vision. This study aimed to check the efficacy and safety of the orthokeratology lens for Indian children.
Dr Ashvin Agarwal, Chief Clinical Officer, Dr Agarwals Eye Hospital said, “By 2050, myopia incidence is projected to reach 50 per cent, driving our collaboration with Menicon to tackle this pressing issue. At Dr Agarwals Eye Hospital, we are committed towards innovation, research and development in eye care in India. Our association with Menicon will help us take the first step towards slowing myopia progression through the introduction of an orthokeratology lens which promises to improve vision for children. Both the organisations will work towards advancing orthokeratology and promoting its adoption for better eye health in India.”
Shunsuke Yamagishi, Regional Director of China & Asia-Oceania International Business Head Office, Menicon said, “With the growing challenges of myopia, our partnership with Dr Agarwals Eye Hospital marks a significant step towards tackling this issue. With our clinical studies in India, we aim to develop solutions and raise awareness about the treatment. We believe that our partnership will create impactful knowledge and treatment in myopia in India and beyond.”
